Martek Biosciences Corporation
Company Cash Flow
| Oct 2007 | Oct 2006 | Oct 2005 | Oct 2004 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 32.01M | 17.81M | 15.28M | 47.05M |
| Operating Gains/Losses | 1.10M | 6.12M | 3.13M | 669.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -9.13M | -5.14M | 9.69M | -17.13M |
| (Increase) Decrease in Inventories | 2.34M | -20.80M | -63.16M | -15.52M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 1.41M | 1.32M |
| (Decrease) Increase In Payables | -3.54M | 5.00M | -10.30M | 9.61M |
| (Decrease) Increase In Other Current Liabilities | -7.64M | 8.53M | 1.52M | 577.00K |
| (Increase) Decrease In Other Working Capital | 471.00K | -2.19M | 0.00 | 0.00 |
| Other Non-Cash Items | 2.78M | -1.09M | 0.00 | 0.00 |
| Net Cash From Continuing Operations | 45.86M | 35.62M | -17.14M | 10.09M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 45.86M | 35.62M | -17.14M | 10.09M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 6.58M | 11.05M | 0.00 | 53.84M |
| Purchases of Property, Plant & Equipment | -18.20M | -24.64M | -57.18M | -180.41M |
| Acquisitions | 900.00K | 0.00 | -315.00K | -355.00K |
| Purchases of Short-Term Investments | 0.00 | 0.00 | -9.10M | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | -402.00K | 1.87M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -10.72M | -13.59M | -66.99M | -125.06M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 85.00M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 2.76M | 2.92M | 100.11M | 32.23M |
| Repayment of Long-Term Debt | -37.01M | -22.01M | -34.88M | -2.75M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 507.00K | 1.59M | 500.00K | 0.00 |
| Net Cash From Financing Activities | -33.74M | -17.50M | 65.74M | 114.49M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 1.40M | 4.53M | -18.40M | -479.00K |
Quotes
News & Commentary
Financials
Company Information
Ratings
Find more premium investing ideas